Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company's business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure.
Ligand's goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. The Company's business model is based on doing what Ligand does best: drug discovery, early-stage drug development, product reformulation and partnering.
Type
Public
HQ
San Diego, US
Founded
1987
Size (employees)
22 (est)
Website
ligand.com
Ligand Pharmaceuticals was founded in 1987 and is headquartered in San Diego, US
Report incorrect company information

Key People/Management at Ligand Pharmaceuticals

John L. Higgins

John L. Higgins

CEO

Ligand Pharmaceuticals Office Locations

Ligand Pharmaceuticals has an office in San Diego
San Diego, US (HQ)
3911 Sorrento Valley Blvd
Show all (1)
Report incorrect company information

Ligand Pharmaceuticals Financials and Metrics

Ligand Pharmaceuticals Financials

Ligand Pharmaceuticals's revenue was reported to be $141.10 m in FY, 2017
USD

Revenue (Q1, 2018)

56.2 m

Gross profit (Q1, 2018)

55.4 m

Gross profit margin (Q1, 2018), %

98.6%

Net income (Q1, 2018)

45.3 m

EBIT (Q1, 2018)

37 m

Market capitalization (22-Jun-2018)

4.2 b

Closing share price (22-Jun-2018)

198.4

Cash (31-Mar-2018)

51 m
Ligand Pharmaceuticals's current market capitalization is $4.2 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

49 m64.5 m71.9 m109 m141.1 m

Revenue growth, %

32%11%52%

Cost of goods sold

5.6 m5.4 m

Gross profit

103.4 m135.7 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

13 m16 m10.6 m15 m14.6 m18.4 m17.7 m29.6 m19.5 m21.6 m29.3 m28 m56.2 m

Cost of goods sold

2.5 m2.5 m1.2 m1.5 m1.1 m955 k720 k999 k341 k903 k788 k

Gross profit

10.5 m13.5 m9.4 m13.5 m13.5 m28.7 m18.8 m20.6 m28.9 m27.1 m55.4 m

Gross profit Margin, %

80%85%89%90%93%97%96%95%99%97%99%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

11.6 m160.2 m97.4 m18.8 m20.6 m

Accounts Receivable

2.2 m12.6 m6.2 m14.7 m25.6 m

Inventories

1.4 m269 k1.6 m1.9 m4.4 m

Current Assets

24.9 m185.2 m215.6 m163.1 m237 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

3.3 m13 m14.5 m180.7 m165.8 m108.2 m93.8 m31.3 m61.4 m86.6 m10.6 m60.2 m51 m

Accounts Receivable

5.5 m4.7 m3.1 m5.8 m7.4 m5.5 m5.5 m11.8 m10 m6.6 m7.1 m13.5 m37.1 m

Inventories

1.8 m1.9 m817 k1.1 m2.8 m802 k1.2 m1.8 m3.8 m4 m7.6 m6.8 m10.5 m

Current Assets

16.6 m33.4 m28.6 m198.5 m191.7 m196.7 m210.3 m133.1 m126.6 m140.7 m174.7 m197.2 m349.1 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

11.4 m10.9 m254.9 m(1.6 m)12.6 m

Depreciation and Amortization

2.7 m2.7 m2.6 m10.6 m11.7 m

Inventories

646 k4.4 m(401 k)(244 k)(843 k)

Accounts Payable

(1.7 m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

100 2.1 m1.3 m1.3 m754 k23.6 m224.5 m6.6 m(5.8 m)50 5.1 m45.3 m

Depreciation and Amortization

1.3 m2.5 m2.7 m2.7 m3 m3 m

Inventories

817 k1.1 m2.8 m(533 k)1.2 m1.8 m3.8 m4 m(1.2 m)(5 m)

Accounts Payable

5.1 m4.9 m7.4 m2.7 m3.1 m2.7 m2.3 m2.8 m6.5 m321 k
USDY, 2018

Financial Leverage

1.6 x
Show all financial metrics
Report incorrect company information

Ligand Pharmaceuticals Online and Social Media Presence

Embed Graph
Report incorrect company information